[On the development of specific immunity in patients treated with monomycin for acutely necrotizing cutaneous leishmaniasis].
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D015643:Erythromycin Ethylsuccinate / Q000627:therapeutic use; D006801:Humans; D007109:Immunity; D007897:Leishmaniasis, Mucocutaneous / Q000276:immunology* / Q000517:prevention & control; D014611:Vaccination
D000900:Anti-Bacterial Agents; D015643:Erythromycin Ethylsuccinate
O vyrabotke spetsificheskogo immuniteta u bol'nykh lechennykh monamitsinom po povodu ostronekrotiziruiushchegosia kozhnogo leĭshmanioza.